Skip to content
Scintria
ToolsGrant writerFunding
HomeLiteratureClinical trialsEvidence LabProtocol packData analysisLearnProjectsLibraryReferencesApplications
Start free
ScintriaStart free

Learn / Public Health / Planning, monitoring and evaluating programmes

Economic evaluation and priority setting

12 minute read · 6-question quiz

Download this lesson as a colour Word or PDF study guide with the figures and answers. Included in paid plans; reading and quizzes stay free.Sign in

What you will learn

  • Compare cost-effectiveness, cost-utility and cost-benefit analysis

  • Calculate a cost per outcome and an incremental cost-effectiveness ratio

  • Discuss equity and affordability alongside cost-effectiveness

Resources are limited, so choices must be made. Economic evaluation compares the costs and consequences of alternative actions to find which gives the best value.

Main types

  • Cost-minimisation: outcomes are equal; choose the cheaper option.
  • Cost-effectiveness analysis (CEA): compares cost per unit of a natural outcome, such as cost per life saved or per case averted.
  • Cost-utility analysis (CUA): compares cost per quality-adjusted life year (QALY) or disability-adjusted life year (DALY) averted, which allows comparison across diseases.
  • Cost-benefit analysis (CBA): values costs and benefits in money terms and reports net benefit or benefit-cost ratio.

Incremental cost-effectiveness ratio

When a new option costs more and works better, the key number is the ICER: the extra cost per extra unit of outcome.

ICER

ICER = (C_new - C_old)/(E_new - E_old)

Compare the ICER with a threshold that reflects what the health system or society is willing to pay per unit of outcome.

Worked example: two malaria interventions

In a population of 100,000 children, compare two options over a year.

  • Option A (current): cost 200,000 dollars, prevents 1,000 cases.
  • Option B (new): cost 320,000 dollars, prevents 1,600 cases.
  • Average cost per case averted: A = 200; B = 200 dollars each.
  • ICER of B versus A = (320,000 − 200,000) / (1,600 − 1,000) = 120,000 / 600 = 200 dollars per extra case averted.

If the system would pay up to 250 dollars per extra case averted, B is good value. If its budget is fixed, the decision also depends on affordability: can it afford the extra 120,000 dollars?

Option A (current)Option B (new)B versus ACost 200,0001,000 cases averted200 per caseCost 320,0001,600 cases averted200 per caseExtra cost 120,000Extra 600 cases avertedICER 200 per case
Comparing options: the ICER looks only at the extra cost and extra effect of switching.

Beyond cost-effectiveness

Cost-effectiveness is one input. Priority-setting must also consider:

  • Equity: do poor or remote groups gain most?
  • Severity of illness and financial risk protection.
  • Budget impact and affordability.
  • Feasibility and workforce.
  • Ethics and values, including a fair process that people can see and challenge.

Health technology assessment (HTA) brings these together to advise on which services and products a health system should cover. Many countries, including those building UHC benefit packages, use explicit criteria.

Value is not just cost

The cheapest option may be the least effective, and a very effective option may be unaffordable. Good decisions weigh cost, effect, equity and feasibility together, in a process people trust.

Models depend on assumptions

Cost-effectiveness numbers rely on estimates of effect, cost and coverage. Always test how results change when these assumptions change (sensitivity analysis).

Check yourself

Choose two ways of reaching the same goal in your area. List the costs and outcomes you would need to compare them.

Summary

  • Economic evaluation compares costs and consequences to help choose between options.

  • CEA uses natural units, CUA uses QALYs or DALYs, and CBA values everything in money.

  • The ICER is extra cost divided by extra effect and is compared with a threshold.

  • Equity, affordability, feasibility and fair process matter alongside cost-effectiveness.

Check your understanding

Question 1
1

A cost-utility analysis typically reports cost per:

Question 2
2

Option A costs 200,000 and averts 1,000 cases; B costs 320,000 and averts 1,600. The ICER of B vs A is:

Question 3
3

Cost-benefit analysis expresses outcomes in:

Question 4
4

Why must affordability be assessed separately from cost-effectiveness?

Question 5
5

Sensitivity analysis tests:

Question 6
6

Health technology assessment is used to:

Draft study guide. Spotted an error or something unclear? Tell us at hello@scintria.com. This is educational material, not clinical or regulatory advice.

Monitoring and evaluationThe global health landscape